At study entry, patients demonstrated immune compromise consistent with prior standard of care, including radiation and alkylating chemotherapy. The baseline mean absolute lymphocyte count (ALC) was ...
Clinical Trials Arena on MSN
ImmunityBio’s glioblastoma regimen boosts survival in mid-stage study
As of 22 January, 19 of the 23 patients who have received treatment are still alive, with the longest evaluable survival ...
Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, particularly in regions with ...
UT Southwestern Medical Center researchers have discovered that increasing the levels of a protein called BACH2 makes ...
Trojan horse” approach may enable ‘antigen-independent’ therapy with potential to treat cancers not traditionally amenable to immunotherapy.
In individuals who started antiretroviral therapy during acute HIV infection, the proliferative capacity of HIV-specific CD8+ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results